Compare Waran Seri I Kokoh Exa Nusantara Tbk. (KOCI-W) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Waran Seri I Kokoh Exa Nusantara Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Waran Seri I Kokoh Exa Nusantara Tbk. trades at Rp6 (market cap 2.79B, 517.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp168 (market cap 651.75B, 848.2K 24h volume). The key difference: UBC Medical Indonesia Tbk. is far larger — about 233.6× Waran Seri I Kokoh Exa Nusantara Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (848.2K versus 517.1K). Which is the better fit depends on your goals.
| KOCI-W | LABS | |
|---|---|---|
Market Cap | 2.79B | 651.75B |
Volume | 517.1K | 848.2K |
Lot | 5.17K | 8.48K |
Turnover | 3.2M | 140.51M |
Average Price | 6.2 | 165.66 |
Value | 3.2M | 140.51M |
Indicative Equilibrium Price | 6 | 168 |
Indicative Equilibrium Volume | 1.11K | 50 |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Waran Seri I Kokoh Exa Nusantara Tbk.
PT Kokoh Exa Nusantara Tbk (the Entity) was established based on Notarial Deed No. 173, dated July 31, 2019 of Dwi Rossulliati, S.H., notary in Mojokerto Regency. The Entity started its commercial operations in 2020. PT Exa Nusa Persada is its ultimate parent entity.
Read more on KOCI-W →About UBC Medical Indonesia Tbk.
PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.
Read more on LABS →
